Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine and Atorvastatin in NASH (NALCAT)
NCT01617772Phase 2Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin, levocarnitine in Nonalcoholic steatohepatitis (NASH), sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
atorvastatinlevocarnitine
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01617772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617772.